Program ID: 1097

You're invited to attend a Live Tarsus Peer to Peer Experience!

Date & Time

Wednesday, November 5, 2025
6:30 PM CT

Location

The Capital Grill
17446 Fiesta Texas Drive
San Antonio, TX 78256
View Map

Speaker(s)

Cecelia Koetting , OD University of Colorado School of Medicine Aurora , CO
  • 2025 DemodeXperience – Demodex Blepharitis Dialogues V2

Program Host(s)

Brian Hess
(214) 402-4878

bhess@tarsusrx.com

Program Coordinator

Janet DeLuca
(848) 844-3839

jdeluca@medforce.net

* These fields are required.

Indication and Important Safety Information

Expand

INDICATIONS AND USAGE

XDEMVY is indicated for the treatment of Demodex blepharitis.

Important Safety Information:

WARNINGS AND PRECAUTIONS

Risk of Contamination: Do not allow the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.

Use with Contact Lenses: XDEMVY contains potassium sorbate, which may discolor soft contact lenses. Contact lenses should be removed prior to instillation of XDEMVY and may be reinserted 15 minutes following its administration.

ADVERSE REACTIONS: The most common adverse reaction with XDEMVY was instillation site stinging and burning which was reported in 10% of patients. Other ocular adverse reactions reported in less than 2% of patients were chalazion/hordeolum and punctate keratitis.

Please see the Full Prescribing Information.